Venlafaxine withdrawal reactions.
Boyd
I W
IW
Adverse Drug Reactions Advisory Committee, Woden, ACT.
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D001007:Anxiety / Q000139:chemically induced*; D003511:Cyclohexanols / Q000009:adverse effects*; D003863:Depression / Q000188:drug therapy; D003866:Depressive Disorder / Q000188:drug therapy; D004244:Dizziness / Q000139:chemically induced; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced*; D012678:Sensation Disorders / Q000139:chemically induced*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D014012:Tinnitus / Q000139:chemically induced; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride